Effect of vitamin E and memantine on functional decline in Alzheimer disease: the TEAM-AD VA cooperative randomized trial (Q30584897)

13 October 2017

Effect of vitamin E and memantine on functional decline in Alzheimer disease: the TEAM-AD VA cooperative randomized trial (English)

1 reference

13 October 2017

1 reference

0 references

randomized experiment

1 reference

Catherine Woodman

27

0 references

Carolyn L Turvey

object named as

Carolyn L Turvey

26

0 references

Suzanne Craft

24

object named as

Suzanne Craft

1 reference

13 October 2017

22

Neil W Kowall

1 reference

13 October 2017

Maurice W Dysken

1

1 reference

13 October 2017

Mary Sano

2

1 reference

13 October 2017

Sanjay Asthana

3

1 reference

13 October 2017

Julia E Vertrees

4

1 reference

13 October 2017

Muralidhar Pallaki

5

1 reference

13 October 2017

Maria Llorente

6

1 reference

13 October 2017

Susan Love

7

1 reference

13 October 2017

Gerard D Schellenberg

8

1 reference

13 October 2017

J Riley McCarten

9

1 reference

13 October 2017

Julie Malphurs

10

1 reference

13 October 2017

Susana Prieto

11

1 reference

13 October 2017

Peijun Chen

12

1 reference

13 October 2017

David J Loreck

13

1 reference

13 October 2017

George Trapp

14

1 reference

13 October 2017

Rajbir S Bakshi

15

1 reference

13 October 2017

Jacobo E Mintzer

16

1 reference

13 October 2017

Judith L Heidebrink

17

1 reference

13 October 2017

Ana Vidal-Cardona

18

1 reference

13 October 2017

Lillian M Arroyo

19

1 reference

13 October 2017

Angel R Cruz

20

1 reference

13 October 2017

Sally Zachariah

21

1 reference

13 October 2017

Mohit P Chopra

23

1 reference

13 October 2017

Stephen Thielke

25

1 reference

13 October 2017

Kimberly A Monnell

28

1 reference

13 October 2017

Kimberly Gordon

29

1 reference

13 October 2017

Julie Tomaska

30

1 reference

13 October 2017

Yoav Segal

31

1 reference

13 October 2017

Peter N Peduzzi

32

1 reference

13 October 2017

Peter D Guarino

33

1 reference

13 October 2017

language of work or name

English

0 references

publication date

1 January 2014

1 reference

The Journal of the American Medical Association

13 October 2017

1 reference

13 October 2017

311

1 reference

13 October 2017

33-44

1 reference

13 October 2017

1

1 reference

Vitamin E and memantine in Alzheimer's disease: clinical trial methods and baseline data

13 October 2017

randomized experiment

0 references

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4109898

Lack of evidence for the efficacy of memantine in mild Alzheimer disease.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4109898

Addressing the challenges to successful recruitment and retention in Alzheimer's disease clinical trials

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4109898

Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4109898

Predictors of nursing home admission among Alzheimer's disease patients with psychosis and/or agitation

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4109898

Clinical characteristics and longitudinal changes of informal cost of Alzheimer's disease in the community

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4109898

Vitamin E and donepezil for the treatment of mild cognitive impairment

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4109898

Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4109898

Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4109898

The ABC of Alzheimer's disease: ADL and improving day-to-day functioning of patients.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4109898

Review of outcome measurement instruments in Alzheimer's disease drug trials: psychometric properties of global scales

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4109898

Nursing home placement is related to dementia progression: experience from a clinical trial. Alzheimer's Disease Cooperative Study.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4109898

The Caregiver Activity Survey (CAS): development and validation of a new measure for caregivers of persons with Alzheimer's disease.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4109898

An inventory to assess activities of daily living for clinical trials in Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4109898

The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4109898

The Alzheimer's disease assessment scale: an instrument for assessing treatment efficacy.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4109898

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4109898

A new rating scale for Alzheimer's disease.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4109898

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4109898

Maximum likelihood estimation for interval-censored data using a Weibull-based accelerated failure time model

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4109898

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4109898

Changes in vitamin E prescribing for Alzheimer patients

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4109898

Memantine treatment in patients with mild to moderate Alzheimer's disease: results of a randomised, double-blind, placebo-controlled 6-month study.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4109898

Memantine treatment in patients with mild to moderate Alzheimer's disease already receiving a cholinesterase inhibitor: a randomized, double-blind, placebo-controlled trial

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4109898

Longitudinal study of effects of patient characteristics on direct costs in Alzheimer disease.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4109898

Memantine treatment in mild to moderate Alzheimer disease: a 24-week randomized, controlled trial.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4109898

Galantamine prolonged-release formulation in the treatment of mild to moderate Alzheimer's disease

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4109898

Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4109898

Memantine in moderate-to-severe Alzheimer's disease

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4109898

A 5-month, randomized, placebo-controlled trial of galantamine in AD. The Galantamine USA-10 Study Group.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4109898

Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4109898

A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4109898

Assessing patient dependence in Alzheimer's disease.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4109898

The impact of self-reported cumulative comorbidity on stroke recovery

26 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24381967

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Co-morbidity adjustment for functional outcomes in community-dwelling older adults

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24381967

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Risk factors for nursing home placement in a population-based dementia cohort

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24381967

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1001/JAMA.2013.282834

1 reference

13 October 2017

1 reference

13 October 2017

1 reference